Clinical Trials Browser

Phase 1/2 × Leukemia × Injections × Clear all

NCT00129558 2013-12-04

A Study to Evaluate PT-523 in Patients With Refractory Leukemia

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia